Advances in Oncology Care Targeted Therapies

被引:5
作者
Beatty, Kristi [1 ]
Winkelman, Christine [2 ]
Bokar, Joseph A. [1 ]
Mazanec, Polly [2 ]
机构
[1] Univ Hosp, Seidman Canc Ctr, Wearn 552,11100 Euclid Ave, Cleveland, OH 44106 USA
[2] Case Western Reserve Univ, Frances Payne Bolton Sch Nursing, Cleveland, OH 44106 USA
关键词
biology; cancer; chemotherapy; oncology; radiation; targeted therapy;
D O I
10.1097/NCI.0b013e3182310178
中图分类号
R47 [护理学];
学科分类号
1011 ;
摘要
The start of the 21st century has produced advances in cancer care that have improved both survival rates and quality of life for many persons diagnosed with cancer. Targeted therapy has given new hope for controlling cancer as a chronic illness. Alone, or in combination with traditional therapies such as surgery, radiation, and/or chemotherapy, this new form of therapy targets malignant cells, halting tumor growth and the potential metastatic spread of disease. Toxicities are limited, but some are serious and may require intensive care. It is imperative for the experienced critical care nurse to have an understanding of these new treatment options and those on the horizon, as these therapies are the future of cancer care. Whereas in previous decades, patients with cancer may not have survived an intensive care admission for treatment complications or advanced disease, many patients now are recovering from life-threatening events, continuing treatment for their disease, and going on to live meaningful, good-quality lives.
引用
收藏
页码:323 / 334
页数:12
相关论文
共 26 条
[1]  
[Anonymous], DEF CANC
[2]  
Biedrzycki Barbara A, 2010, Oncol Nurs Forum, V37, pE387, DOI 10.1188/10.ONF.E387-E399
[3]   Targeted Therapies as Adjuvant Treatment for Early-Stage Colorectal Cancer: First Impressions and Clinical Questions [J].
Chibaudel, Benoist ;
Tournigand, Christophe ;
Andre, Thierry ;
Larsen, Annette K. ;
de Gramont, Aimery .
CLINICAL COLORECTAL CANCER, 2010, 9 (05) :269-273
[4]  
Christodoulou C, 2007, ANTICANCER RES, V27, P2945
[5]   Performance of prognostic models in critically ill cancer patients - a review [J].
den Boer, S ;
de Keizer, NF ;
de Jonge, E .
CRITICAL CARE, 2005, 9 (04) :R458-R463
[6]  
Esper P, 2007, CLIN J ONC NURS, V11
[7]  
Gerber DE, 2008, AM FAM PHYSICIAN, V77, P311
[8]  
Gobel BH, 2007, ONCOL NURS FORUM, V12, P356
[9]   Increased Risk of Serious Hemorrhage with Bevacizumab in Cancer Patients: A Meta-Analysis [J].
Hapani, Sanjaykumar ;
Sher, Amna ;
Chu, David ;
Wu, Shenhong .
ONCOLOGY, 2010, 79 (1-2) :27-38
[10]   Intensify, resuscitate or palliate: Decision making in the critically ill patient with haematological malignancy [J].
Hill, Quentin A. .
BLOOD REVIEWS, 2010, 24 (01) :17-25